Vaginal estrogen
Local relief for genitourinary symptoms.
VIDEO LESSON
How it's taken
• Cream, tablet or insert: nightly for about 2 weeks, then twice weekly
• Ring: replaced every 3 months
Side effects at a glance
• Mild irritation or discharge
• Occasional spotting or breast tenderness
Monitoring
Report any postmenopausal bleeding. Low-dose vaginal estrogen does not usually require a progestogen.
Good to know
It reduces recurrent urinary tract infections in postmenopausal women and can be used long term. Symptoms return when treatment stops.
AT A GLANCE
Class
Local therapy
Brand names
Estrace cream, Premarin cream, Vagifem, Yuvafem, Imvexxy, Estring
Status
FDA-approved
Reviewed by
Farhan Tahir, MD
Is this medicine right for you?
Prescription medicines need individual medical advice. Dr. Tahir’s team offers consults through Youthful Medicine.
MECHANISM
How it works
Low-dose estrogen delivered as a cream, tablet, insert or ring. It restores the thickness, moisture, elasticity and acidity of vaginal and urinary tissue, with very little reaching the bloodstream.
THE EVIDENCE
What the research actually shows.
EVIDENCE SUMMARY
Genitourinary syndrome of menopause (dryness, painful sex, urgency and recurrent infections) is common after menopause and, unlike hot flashes, tends to progress without treatment. The Menopause Society’s 2020 position statement supports low-dose vaginal estrogen as effective prescription therapy, and it can reduce recurrent urinary tract infections.
KEY TRIALS
Menopause Society GSM statement (2020)
TYPICAL RESULT
Symptom relief within weeks; ongoing use keeps it
SAFETY
Risks, side effects and who should avoid it
Very low systemic absorption at standard doses, and a progestogen is generally not needed. Women with a history of breast cancer should decide together with their oncology team. Non-hormonal moisturizers and lubricants are an option for everyone.
This summary is not a complete list of risks. Read the official prescribing information and discuss your own history with your clinician.
KEY REFERENCE
The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27(9):976–992.
Educational content only, reviewed by Farhan Tahir, MD. Not individual medical advice. Medicines named here require a prescription and medical supervision.